Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
226
PUT
Broadcom
AVGO
$1.58T
| $275M | 0.05% |
781,700
-1,084,700
| -58% | -$408M |
2024 Q3
8 quarters
|
|
227
Vertex Pharmaceuticals
VRTX
$139B
| $274M | 0.05% |
524,679
-208,595
| -28% | -$107M |
2013 Q2
53 quarters
|
|
228
Datadog
DDOG
$64.4B
| $272M | 0.05% |
994,509
+25,813
| +3% | +$6.38M |
2022 Q1
18 quarters
|
|
229
CALL
Sandisk
SNDK
$122B
| $268M | 0.05% |
154,100
+83,800
| +119% | +$131M |
2025 Q1
6 quarters
|
|
230
Eaton
ETN
$138B
| $265M | 0.05% |
617,232
+148,451
| +32% | +$62M |
2013 Q4
51 quarters
|
|
231
Regeneron Pharmaceuticals
REGN
$94.8B
| $264M | 0.05% |
348,437
+92,245
| +36% | +$69.7M |
2013 Q2
53 quarters
|
|
232
PUT
Eli Lilly
LLY
$1.28T
| $262M | 0.05% |
226,100
+91,800
| +68% | +$108M |
2024 Q3
8 quarters
|
|
233
iShares MBS ETF
MBB
$35.6B
| $261M | 0.05% |
2,907,852
+2,723,432
| +1,477% | +$253M |
2025 Q2
5 quarters
|
|
234
DTE Energy
DTE
$28.9B
| $261M | 0.05% |
2,139,252
+506,155
| +31% | +$70.3M |
2013 Q2
53 quarters
|
|
235
Applovin
APP
$131B
| $257M | 0.05% |
886,523
-174,710
| -16% | -$64.3M |
2022 Q1
18 quarters
|
|
236
Moody's
MCO
$88.1B
| $255M | 0.05% |
561,926
-44,307
| -7% | -$21.5M |
2013 Q2
53 quarters
|
|
237
Mondelez International
MDLZ
$84.2B
| $253M | 0.05% |
4,379,413
+828,030
| +23% | +$50.9M |
2013 Q2
53 quarters
|
|
238
Broadridge
BR
$21.8B
| $253M | 0.05% |
1,569,997
-253,642
| -14% | -$41.4M |
2013 Q2
53 quarters
|
|
239
Blackstone
BX
$96.9B
| $250M | 0.05% |
2,232,944
-1,641,031
| -42% | -$215M |
2022 Q1
18 quarters
|
|
240
Prologis
PLD
$124B
| $247M | 0.05% |
1,899,199
-1,182,218
| -38% | -$166M |
2013 Q2
53 quarters
|
|
241
CME Group
CME
$111B
| $245M | 0.05% |
934,585
-232,375
| -20% | -$61.3M |
2013 Q2
53 quarters
|
|
242
Ameren
AEE
$31.5B
| $245M | 0.05% |
2,461,412
-116,197
| -5% | -$12.5M |
2013 Q2
53 quarters
|
|
243
Accenture
ACN
$153B
| $242M | 0.05% |
1,320,861
-222,778
| -14% | -$37.6M |
2013 Q4
51 quarters
|
|
244
SLB Ltd
SLB
$73.7B
| $242M | 0.05% |
4,966,769
+1,508,058
| +44% | +$77.7M |
2013 Q2
53 quarters
|
|
245
Southern Company
SO
$109B
| $242M | 0.05% |
2,917,670
+216,492
| +8% | +$19.7M |
2013 Q2
53 quarters
|
|
246
Danaher
DHR
$166B
| $240M | 0.05% |
1,084,479
-111,863
| -9% | -$23M |
2013 Q2
53 quarters
|
|
247
CALL
Akamai
AKAM
$12.1B
| $240M | 0.05% |
2,253,400
+240,200
| +12% | +$27.4M |
2024 Q2
9 quarters
|
|
248
PUT
Amphenol
APH
$197B
| $239M | 0.05% |
2,837,200
+2,266,200
| +397% | +$183M |
2026 Q1
2 quarters
|
|
249
Abbott
ABT
$191B
| $237M | 0.05% |
2,402,592
-1,460,882
| -38% | -$153M |
2013 Q2
53 quarters
|
|
250
State Street Technology Select Sector SPDR ETF
XLK
$112B
| $236M | 0.05% |
1,206,358
-360,584
| -23% | -$66.6M |
2013 Q2
53 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.